Healthcare provider profile · identity verified

Aaron A Dunn, MD

Family Practice · MINERAL POINT, WI · NPI 1275598328

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	650	175
Lisinopril	Lisinopril	363	88
Omeprazole	Omeprazole	319	85
Levothyroxine Sodium	Levothyroxine Sodium	318	68
Metoprolol Succinate	Metoprolol Succinate	292	76
Rosuvastatin Calcium	Rosuvastatin Calcium	275	96
Amlodipine Besylate	Amlodipine Besylate	270	70
Eliquis	Apixaban	223	34
Furosemide	Furosemide	177	52
Gabapentin	Gabapentin	161	34
Losartan Potassium	Losartan Potassium	156	46
Metoprolol Tartrate	Metoprolol Tartrate	148	42
Metformin Hcl	Metformin Hcl	132	30
Jardiance	Empagliflozin	123	22
Metformin Hcl Er	Metformin Hcl	120	34
Trulicity	Dulaglutide	115	15
Trazodone Hcl	Trazodone Hcl	113	26
Carvedilol	Carvedilol	105	24
Fluticasone Propionate	Fluticasone Propionate	103	43
Tamsulosin Hcl	Tamsulosin Hcl	99	33
Pantoprazole Sodium	Pantoprazole Sodium	97	25
Warfarin Sodium	Warfarin Sodium	95	30
Allopurinol	Allopurinol	92	24
Finasteride	Finasteride	90	22
Spironolactone	Spironolactone	89	21
Escitalopram Oxalate	Escitalopram Oxalate	88	22
Potassium Chloride	Potassium Chloride	88	21
Sertraline Hcl	Sertraline Hcl	86	15
Famotidine	Famotidine	85	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	85	14
Ozempic	Semaglutide	84	15
Xarelto	Rivaroxaban	83	14
Albuterol Sulfate Hfa	Albuterol Sulfate	81	27
Arnuity Ellipta	Fluticasone Furoate	77	14
Mirtazapine	Mirtazapine	76	11
Prednisone	Prednisone	75	38
Glipizide Er	Glipizide	73	22
Breo Ellipta	Fluticasone/Vilanterol	72	13
Citalopram Hbr	Citalopram Hydrobromide	72	16
Lorazepam	Lorazepam	71	17
Montelukast Sodium	Montelukast Sodium	69	20
Bumetanide	Bumetanide	67	14
Pravastatin Sodium	Pravastatin Sodium	66	22
Duloxetine Hcl	Duloxetine Hcl	65	12
Donepezil Hcl	Donepezil Hcl	63	suppressed
Simvastatin	Simvastatin	63	16
Bupropion Xl	Bupropion Hcl	62	suppressed
Olanzapine	Olanzapine	62	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	18
Quetiapine Fumarate	Quetiapine Fumarate	56	suppressed
Clopidogrel	Clopidogrel Bisulfate	55	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	54	11
Terazosin Hcl	Terazosin Hcl	53	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	50	12
Topiramate	Topiramate	49	suppressed
Tramadol Hcl	Tramadol Hcl	49	24
Oxybutynin Chloride Er	Oxybutynin Chloride	47	16
Venlafaxine Hcl Er	Venlafaxine Hcl	46	11
Azelastine Hcl	Azelastine Hcl	43	15
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Paroxetine Hcl	Paroxetine Hcl	42	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	suppressed
Enalapril Maleate	Enalapril Maleate	37	12
Glipizide	Glipizide	37	11
Pregabalin	Pregabalin	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	13
Alendronate Sodium	Alendronate Sodium	35	suppressed
Incruse Ellipta	Umeclidinium Bromide	32	suppressed
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	22
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Digoxin	Digoxin	30	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	30	11
Ipratropium Bromide	Ipratropium Bromide	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Budesonide Dr	Budesonide	29	suppressed
Meloxicam	Meloxicam	28	suppressed
Solifenacin Succinate	Solifenacin Succinate	28	suppressed
Alprazolam	Alprazolam	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Loperamide	Loperamide Hcl	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Nystatin	Nystatin	26	15
Risperidone	Risperidone	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Nitroglycerin	Nitroglycerin	25	16
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	16
Latanoprost	Latanoprost	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	15
Atenolol	Atenolol	20	suppressed
Cefprozil	Cefprozil	20	19
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Amoxicillin	Amoxicillin	19	14
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	19	suppressed
Clonazepam	Clonazepam	19	suppressed
Fenofibrate	Fenofibrate,micronized	19	suppressed
Haloperidol	Haloperidol	19	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	11
Fluvoxamine Maleate	Fluvoxamine Maleate	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Budesonide	Budesonide	17	suppressed
Dantrolene Sodium	Dantrolene Sodium	17	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Belsomra	Suvorexant	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Baclofen	Baclofen	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Lactulose	Lactulose	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Estradiol	Estradiol	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Prevalite	Cholestyramine	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Buprenorphine	Buprenorphine	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Olanzapine Odt	Olanzapine	11	suppressed
Ramipril	Ramipril	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed
Zenpep	Lipase/Protease/Amylase	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error